'For quarter ending June 2024, consolidated Net sales (including other operating income) of Sanofi India has declined 9.98% to Rs 463.5 crore compared to quarter ended June 2023. Operating profit margin has jumped from 23.62% to 24.96%, leading to 4.85% decline in operating profit to Rs 115.70 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 17.97% to 19.69%. Purchase of finished goods cost fell from 33.52% to 22.18%. Employee cost increased from 13.15% to 14.44%. Other expenses rose from 12.53% to 15.95%.
Other income fell 69.03% to Rs 4.8 crore. PBIDT fell 12.11% to Rs 120.5 crore. Provision for interest fell 42.86% to Rs 0.4 crore. Loan funds rose to Rs 22.10 crore as of 30 June 2024 from Rs 19.50 crore as of 30 June 2023. Inventories declined from Rs 411.60 crore as of 30 June 2023 to Rs 356.20 crore as of 30 June 2024. ...
Pleaselogin & subscribe to view the full report.
More Reports
-
(01-Mar-2025)
Foseco India
-
Maintains double digit revenue growth and stable OPM
-
(28-Feb-2025)
Sanofi India
-
Net up 33% largely on higher sales, higher OI and lower taxation
|
|